D.E. Shaw & Co
SWAV

D.E. Shaw & Co’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

D.E. Shaw & Co’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,000
Closed -$3.26M – 4940
2024
Q1 		$3.26M Hold
10,000
– – ﹤0.01% 2241
2023
Q4 		$1.91M Hold
10,000
– – ﹤0.01% 2706
2023
Q3 		$1.99M Buy
+10,000
New +$2.36M ﹤0.01% 2571
2023
Q1 		– Sell
-10,900
Closed -$2.24M – 4995
2022
Q4 		$2.24M Sell
10,900
-2,700
-20% -$683K ﹤0.01% 2843
2022
Q3 		$3.78M Buy
+13,600
New +$3.46M ﹤0.01% 2392
2022
Q1 		– Sell
-20,000
Closed -$3.57M – 6065
2021
Q4 		$3.57M Buy
20,000
+4,100
+26% +$809K ﹤0.01% 2767
2021
Q3 		$3.27M Buy
15,900
+5,900
+59% +$1.16M ﹤0.01% 2543
2021
Q2 		$1.9M Buy
+10,000
New +$1.64M ﹤0.01% 2993
2020
Q3 		– Sell
-20,000
Closed -$947K – 4249
2020
Q2 		$947K Buy
+20,000
New +$824K ﹤0.01% 2982

Other funds holding SWAV

SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
UWS
Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

D.E. Shaw & Co's SWAV Position: Q1 2024 in Review

D.E. Shaw & Co sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2024, closing a stake of 1,617 shares — an estimated $397K sold.

D.E. Shaw & Co first reported a position in SWAV in Q2 2020 and held it in 14 quarters. The position peaked at $38.8M in Q2 2021. 488 funds tracked by Wall St. Rank hold SWAV as of Q1 2024.

  • D.E. Shaw & Co reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • D.E. Shaw & Co sold 1,617 Shockwave Medical, Inc. Common Stock shares in Q1 2024, an estimated $397K.
  • D.E. Shaw & Co first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2020 and held it in 14 quarters.
  • D.E. Shaw & Co's Shockwave Medical, Inc. Common Stock position peaked at $38.8M in Q2 2021.
  • 488 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2024.

Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.